Avisio forms new subsidiary to market its virus detecting nano sensory technology

Dec 3 2009NewsGuard 100/100 Score

Avisio, Inc. (PINKSHEETS: AVIC) announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses. The new company, Diagnostic Nano Applications (DNA), will be headquartered in Riverside, California.

Instant Detect is a portable nano-based technology that operates in the field and provides immediately-available results that do not require the expertise of a specialized lab technician to read. The technology is expected to be used by individuals in the health care and agricultural industries to detect disease-causing pathogens that can impact global food supplies and human health.

Source:

Avisio, Inc.

Posted in: Medical Science News

Tags: , , , , , ,

Comments (0)

Suggested Reading

Elevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis
Pasteurization effectively reduces H5N1 virus in milk but further testing is essential
CDC identifies new Oropouche virus cases in U.S. travelers, raising public health concerns
FDA commercial pasteurization process kills H5N1 bird flu virus in milk
Scientists detect replication-competent Oropouche virus in semen of traveler, sparking transmission fears
Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy
Squid-inspired technology could replace needles for medications and vaccines
Engineered virus-like particles evolve for superior gene delivery efficiency

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Vaccines and virus changes cut long COVID risk by 50%, but Omicron still poses a threat